Mereo BioPharma(MREO) - 2025 Q2 - Quarterly Report

Table of Contents FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 For the quarterly period ended June 30, 2025 OR MEREO BIOPHARMA GROUP PLC (Exact name of Registrant as specified in its charter) | England and Wales | | Not Applicable | | --- | --- | --- | | (State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) | | th One Cavendish Place ...